Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 51.17
-0.61 (-1.18%)
Nov 6, 2026, 2:45 PM CST
SHE:300841 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 310.36 | 1,151 | 1,001 | 1,039 | 651.46 | 926.88 |
Trading Asset Securities | 877.91 | - | - | - | - | - |
Cash & Short-Term Investments | 1,188 | 1,151 | 1,001 | 1,039 | 651.46 | 926.88 |
Cash Growth | 25.99% | 14.95% | -3.66% | 59.54% | -29.71% | -31.11% |
Accounts Receivable | 1,337 | 1,226 | 1,299 | 1,411 | 1,287 | 837.18 |
Other Receivables | 0.85 | 0.29 | 0.78 | 16.38 | 17.72 | 2.58 |
Receivables | 1,338 | 1,226 | 1,300 | 1,427 | 1,305 | 839.76 |
Inventory | 120.41 | 140.81 | 176.88 | 173.54 | 153.65 | 105.49 |
Other Current Assets | 12.2 | 5.53 | 10.14 | 17.09 | 35.19 | 70.46 |
Total Current Assets | 2,659 | 2,523 | 2,488 | 2,657 | 2,145 | 1,943 |
Property, Plant & Equipment | 785.5 | 880 | 958.95 | 961.29 | 985.45 | 488.72 |
Long-Term Investments | 402.45 | 404.42 | 416.38 | 477.37 | 502.47 | 468.57 |
Other Intangible Assets | 13.93 | 15.71 | 17.51 | 15.38 | 17.23 | 18.77 |
Long-Term Deferred Tax Assets | 7.62 | 6.85 | 2.07 | - | - | 7.04 |
Long-Term Deferred Charges | 499.9 | 177.11 | 142.52 | 94.39 | 53.76 | 36.07 |
Other Long-Term Assets | 4.47 | 2.48 | 2.15 | 3.94 | 7.05 | 56.29 |
Total Assets | 4,403 | 4,010 | 4,028 | 4,209 | 3,711 | 3,018 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1.89 | 2.95 | 5.9 | 7.13 | 34.14 | 6.06 |
Accrued Expenses | 27.46 | 234.33 | 256.31 | 349.01 | 264.37 | 211.81 |
Short-Term Debt | - | 139.9 | 186.89 | 190.91 | 109.3 | - |
Current Portion of Long-Term Debt | - | - | - | - | 1 | - |
Current Portion of Leases | - | - | - | - | 0.31 | 0.59 |
Current Income Taxes Payable | 23.21 | 22.66 | 2.3 | 27.71 | 12.58 | 21.97 |
Current Unearned Revenue | 0.4 | 0.51 | 1 | 0.3 | 0.23 | - |
Other Current Liabilities | 305.16 | 38.98 | 113.97 | 106.67 | 189.78 | 98.5 |
Total Current Liabilities | 358.12 | 439.32 | 566.37 | 681.72 | 611.71 | 338.94 |
Long-Term Debt | - | - | - | - | 15.75 | - |
Long-Term Leases | 3.48 | - | - | - | - | 0.31 |
Long-Term Unearned Revenue | 7.34 | 8.11 | 6.17 | 6.2 | - | - |
Long-Term Deferred Tax Liabilities | 75.05 | - | - | 2.5 | 3.96 | 4.73 |
Other Long-Term Liabilities | 27.89 | 24.88 | 7.54 | 4.79 | 3.98 | 3.77 |
Total Liabilities | 471.87 | 472.31 | 580.07 | 695.22 | 635.4 | 347.74 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 129.95 | 129.95 | 132.95 | 134.65 | 134.65 | 90 |
Additional Paid-In Capital | 862.61 | 861.15 | 1,082 | 1,180 | 1,184 | 1,220 |
Retained Earnings | 2,709 | 2,546 | 2,456 | 2,323 | 1,881 | 1,416 |
Treasury Stock | - | - | -224.34 | -123.1 | -123.1 | -55.88 |
Shareholders' Equity | 3,931 | 3,537 | 3,448 | 3,514 | 3,076 | 2,670 |
Total Liabilities & Equity | 4,403 | 4,010 | 4,028 | 4,209 | 3,711 | 3,018 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 3.48 | 139.9 | 186.89 | 190.91 | 126.35 | 0.9 |
Net Cash (Debt) | 1,185 | 1,011 | 814.44 | 848.45 | 525.11 | 925.98 |
Net Cash Growth | 49.36% | 24.15% | -4.01% | 61.58% | -43.29% | -31.18% |
Net Cash Per Share | 9.12 | 7.78 | 6.19 | 6.34 | 3.92 | 6.88 |
Filing Date Shares Outstanding | 129.95 | 129.95 | 129.95 | 133.75 | 133.75 | 134.46 |
Total Common Shares Outstanding | 129.95 | 129.95 | 129.95 | 133.75 | 133.75 | 134.5 |
Working Capital | 2,301 | 2,084 | 1,922 | 1,975 | 1,533 | 1,604 |
Book Value Per Share | 28.48 | 27.22 | 26.53 | 26.27 | 23.00 | 19.85 |
Tangible Book Value | 3,657 | 3,522 | 3,430 | 3,499 | 3,058 | 2,652 |
Tangible Book Value Per Share | 28.14 | 27.10 | 26.40 | 26.16 | 22.87 | 19.71 |
Buildings | - | 613.12 | 609.54 | 450.84 | 307.46 | 166.34 |
Machinery | - | 578.77 | 568.27 | 548.01 | 276.66 | 177.54 |
Construction In Progress | - | - | 3.04 | 112.25 | 523.35 | 238.71 |